HKUST-led int'l research achieves breakthrough in Alzheimer's diagnosis, management

STORY: HKUST-led int'l research achieves breakthrough in Alzheimer's diagnosis, management SHOOTING TIME: Feb. 19, 2024 DATELINE: Feb. 21, 2024 LENGTH: 00:01:21 LOCATION: HONG KONG, China CATEGORY: HEALTH SHOTLIST: 1. various of the press conference STORYLINE: The international research collaboration led by the Hong Kong University of Science and Technology (HKUST) has reached a significant milestone in the diagnosis and management of Alzheimer's disease (AD), according to a press conference on Monday in Hong Kong. Spearheaded by Prof. Nancy Ip, President and the Morningside Professor of Life Science at HKUST, and Director of the Hong Kong Center for Neurodegenerative Diseases (HKCeND), the team has developed an innovative blood test for the early detection of AD and mild cognitive impairment (MCI), boasting accuracy rates of over 96 percent and 87 percent, respectively. Alzheimer's disease affects over 50 million people worldwide, characterized by the accumulation of toxic amyloid beta in the brain, lea

Japan's 3rd 'domino' liver transplants go smoothly

Japan's 3rd 'domino' liver transplants go smoothly

TOKYO, Japan - Keio University Hospital surgeons remove the liver of a patient in his 20s with familial amyloid polyneuropathy Feb. 21, in Japan's third ''domino'' liver transplants. The patient will receive part of his father's liver, and the removed liver was later transported from Keio hospital in Tokyo to Kyoto University Hospital in western Japan, where it will be divided for transplant into two males in their 30s with critical liver diseases. Photo was provided by Keio hospital.